Literature DB >> 7712232

Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.

M A Chesney1, P Lurie, T J Coates.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7712232

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


× No keyword cloud information.
  5 in total

Review 1.  Building and testing an effective HIV vaccine.

Authors:  J Kahn
Journal:  West J Med       Date:  1999 Nov-Dec

Review 2.  What about the ethics?

Authors:  L E Wolf; B Lo
Journal:  West J Med       Date:  1999 Nov-Dec

Review 3.  Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa.

Authors:  Joalida Smit; Keren Middelkoop; Landon Myer; Graham Lindegger; Leslie Swartz; Soraya Seedat; Tim Tucker; Robin Wood; Linda-Gail Bekker; Dan J Stein
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

4.  Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

Authors:  P Brown-Peterside; M A Chiasson; L Ren; B A Koblin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

5.  Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Authors:  R I Connor; B T Korber; B S Graham; B H Hahn; D D Ho; B D Walker; A U Neumann; S H Vermund; J Mestecky; S Jackson; E Fenamore; Y Cao; F Gao; S Kalams; K J Kunstman; D McDonald; N McWilliams; A Trkola; J P Moore; S M Wolinsky
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.